SHANGHAI, Nov. 14, 2019 /PRNewswire/ -- 111, Inc.
(NASDAQ: YI) ("111" or the "Company"), a leading integrated online
and offline healthcare platform, announced today that it will
establish an integrated online and offline healthcare retail
channel with HEC Group ("HEC"). The channel will be used to expand
the offering of HEC's products and resources to more patients, both
online and offline.
The signing ceremony was conducted by Yushuai Zhang, Chairman of
Guangdong HEC Technology Holding Co., Ltd. (SH: 600673),
Yangui Chen, Executive Director of
Yichang HEC, Dr. Gang Yu, Co-Founder and Executive Chairman of 111,
Haihui Wang, Chief Operating Officer
of 111, and Yang Chen, Chief
Financial Officer of 111. HEC is the parent company of Yichang HEC
Changjiang Pharmaceutical Co., Ltd. ("Yichang HEC") (01558.HK).
Under the partnership, in addition to focusing on cardio
cerebrovascular and endocrine diseases, 111 will support HEC in
designing solutions for direct sourcing, distribution management,
and e-commerce, and both parties will also collaborate on brand
visibility and patient education.
Haihui Wang, Chief Operating
Officer of 111, commented: "As the healthcare needs of China continue to grow, 111 is empowering
pharmaceutical companies to bring innovative products to
market. We are constantly enriching the product verticals on
our platforms to serve the needs of patients. We have been very
impressed by HEC's manufacturing quality management system, the
range of its products offerings, and innovative products."
Yangui Chen, Executive Director
of Yichang HEC, commented: "Yichang HEC is an advocate of diagnosis
and treatment based on advanced scientific method. "KeWei"
Oseltamivir Phosphate Granules is a top influenza drug
internationally and domestically, and the HEC Group has global
exclusive rights to produce it. With the development of clinical
and consumer awareness about influenza, an increasing number of
people have heard of Oseltamivir, have used this drug, and are
gradually learning about HEC. We are planning to use a range of
market distribution channels for our innovative products in the
future. The Internet makes it possible to provide precise
information to patients, and the new distribution channel outside
hospitals that we will develop with 111 will be an important
strategic departure for us."
China's healthcare reforms are
bringing unprecedented changes to the traditional pharmaceutical
distribution market. Pharmaceutical manufacturers are under
pressure to switch their focus to new drug development. At the same
time, China has allowed
conditional online prescription drug sales, and the Internet
Drug Sale Supervision Measures are under review. 111 is ideally
positioned in the market as the Chinese government is liberalizing
drug distribution beyond hospitals.
About HEC Group
HEC Group was founded in 1997. It has 20,000 employees. The
Company operates in biomedicine, electronic materials and
healthcare industries. It has six production centers in
Dongguan and Shaoguan in
Guangzhou province, Yichang in
Hubei province, Linzhi in Tibet,
Zunyi in Guizhou province, and
Wulanchabu in Inner Mongolia. It has two listing companies
including Guangdong HEC Technology Holding Co., Ltd. (SH: 600673)
and Yichang HEC Changjiang Pharmaceutical Co., Ltd. ("Yichang HEC")
For more information on HEC Group, please visit
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading
integrated online and offline healthcare platform in China. The Company provides hundreds of
millions of consumers with better access to pharmaceutical products
and healthcare se rvices directly through its online retail
pharmacy and indirectly through its offline pharmacy network. 111
also offers online healthcare services through its internet
hospital, 1 Clinic, which provides consumers with cost-effective
and convenient online consultation and electronic prescription
services. In addition to providing direct services to consumers
through its online retail pharmacy, 111 also enables offline
pharmacies to better serve their customers. The Company's online
wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for
pharmacies to source a vast selection of pharmaceutical products.
The Company's new retail platform, by integrating the front and
back ends of the pharmaceutical supply chain, has formed a smart
supply chain, which transforms the flow of pharmaceutical products
to pharmacies and modernizes how they serve their customers.
For more information on 111, please visit
For more information, please contact:
Ms. Monica Mu
Mr. Christian Arnell
Ms. Linda Bergkamp
SOURCE 111, Inc.